Versor Investments LP — 13F Holdings & Portfolio

CIK 1650301 · latest 13F-HR filed 2026-08-07

Versor Investments LP manages $47.5M in 13F-reported U.S. long-equity assets across 27 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NUVL (6.72%), JHG (6.39%), TECH (6.25%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 10 new positions, exited 14, added to 15, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
1120 AVENUE OF THE AMERICAS
15 FL
NEW YORK, NY 10036
Phone
(212) 626-6508
Filing Manager
Versor Investments LP
New York, NY
Signatory
Andrew Flynn
Chief Operating Officer
Loading holdings…
AUM

$47.5M

Long-equity book

Holdings

27

Distinct positions

Period

2026-06-30

Filed 2026-08-07

Q/Q Activity

+10 / −14 / ↑15 / ↓1

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • UNIFIRST CORP MASS$1.8M +352.7%
  • NCR ATLEOS CORPORATION$1.4M +248.6%
  • SILICON LABORATORIES INC$1.2M +102.3%
  • AES CORP$1.1M +267.8%
  • VALARIS LTD$764.7K +83.3%
Show all 15 →

Top Trims

  • CHART INDS INC-$186.8K -20.7%
Show all 1 →

New Positions

  • NUVALENT INC$3.2M
  • BIO-TECHNE CORP$3.0M
  • APOGEE THERAPEUTICS INC$2.4M
  • CATALYST PHARMACEUTICALS INC$2.4M
  • LEGGETT & PLATT INC$1.6M
Show all 10 →

Exited Positions

  • DAY ONE BIOPHARMACEUTICALS I$2.7M
  • APELLIS PHARMACEUTICALS INC$2.1M
  • AMICUS THERAPEUTIC$2.0M
  • GREAT LAKES DREDGE & DOCK CO$1.7M
  • THERMON GROUP HLDGS INC$1.6M
Show all 14 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 NUVALENT INC NUVL 670703107 $3.2M 6.72% 25,850 SH
2 JANUS HENDERSON GROUP PLC JHG G4474Y214 $3.0M 6.39% 58,456 SH
3 BIO-TECHNE CORP TECH 09073M104 $3.0M 6.25% 42,050 SH
4 NORFOLK SOUTHN CORP NSC 655844108 $2.7M 5.65% 8,532 SH
5 SELECT MED HLDGS CORP SEM 81619Q105 $2.7M 5.64% 162,328 SH
6 TALKSPACE INC TALK 87427V103 $2.5M 5.23% 478,470 SH
7 APOGEE THERAPEUTICS INC APGE 03770N101 $2.4M 5.09% 18,222 SH
8 CATALYST PHARMACEUTICALS INC CPRX 14888U101 $2.4M 5.04% 76,286 SH
9 UNIFIRST CORP MASS UNF 904708104 $2.3M 4.89% 8,782 SH
10 SILICON LABORATORIES INC SLAB 826919102 $2.3M 4.84% 10,530 SH
11 ELECTRONIC ARTS INC EA 285512109 $2.2M 4.71% 10,919 SH
12 PENUMBRA INC PEN 70975L107 $2.0M 4.31% 6,491 SH
13 NCR ATLEOS CORPORATION NATL 63001N106 $1.9M 4.01% 43,921 SH
14 QORVO INC QRVO 74736K101 $1.9M 3.89% 19,836 SH
15 STELLAR BANCORP INC STEL 858927106 $1.8M 3.82% 46,173 SH
16 VALARIS LTD VAL G9460G101 $1.7M 3.54% 23,176 SH
17 LEGGETT & PLATT INC LEG 524660107 $1.6M 3.26% 132,455 SH
18 AES CORP AES 00130H105 $1.5M 3.06% 99,295 SH
19 WARNER BROS DISCOVERY INC WBD 934423104 $1.3M 2.81% 50,068 SH
20 ORGANON & CO OGN 68622V106 $1.2M 2.50% 87,640 SH
21 DIGITALBRIDGE GROUP INC DBRG 25401T603 $879.4K 1.85% 55,729 SH
22 CHART INDS INC GTLS 16115Q308 $715.6K 1.51% 3,425 SH
23 LIVERAMP HLDGS INC RAMP 53815P108 $689.9K 1.45% 18,328 SH
24 ESSENTIAL UTILS INC WTRG 29670G102 $603.8K 1.27% 15,762 SH
25 DOMINION ENERGY INC D 25746U109 $501.8K 1.06% 7,348 SH
26 ARCOSA INC ACA 039653100 $358.7K 0.75% 2,469 SH
27 ROKU INC ROKU 77543R102 $216.3K 0.46% 1,566 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-07 $47.5M 27 0001172661-26-003147
2026-03-31 2026-05-12 $40.8M 31 0001172661-26-001717
2025-12-31 2026-02-04 $641.8M 590 0001172661-26-000470
2025-09-30 2025-11-06 $543.3M 606 0001172661-25-004600
2022-06-30 2022-07-27 $2.6M 777 0001172661-22-001666
2022-03-31 2022-05-04 $2.7M 603 0001172661-22-001166
2021-06-30 2021-07-27 $2.8M 340 0001172661-21-001551